Back to Search
Start Over
Correction: Olaparib not cost-effective as maintenance therapy for platinum-sensitive, BRCA1/2 germline-mutated metastatic pancreatic cancer.
- Source :
-
PloS one [PLoS One] 2024 Dec 12; Vol. 19 (12), pp. e0315976. Date of Electronic Publication: 2024 Dec 12 (Print Publication: 2024). - Publication Year :
- 2024
-
Abstract
- [This corrects the article DOI: 10.1371/journal.pone.0301271.].<br /> (Copyright: © 2024 Mehra et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
Details
- Language :
- English
- ISSN :
- 1932-6203
- Volume :
- 19
- Issue :
- 12
- Database :
- MEDLINE
- Journal :
- PloS one
- Accession number :
- 39666698
- Full Text :
- https://doi.org/10.1371/journal.pone.0315976